LAURUSLABS

Laurus Labs Share Price

₹489.00 0.00 (0.00%)

21 Nov, 2024 14:43

SIP TrendupStart SIP in LAURUSLABS

Start SIP

Performance

  • Low
  • ₹483
  • High
  • ₹492
  • 52 Week Low
  • ₹361
  • 52 Week High
  • ₹518
  • Open Price₹489
  • Previous Close₹489
  • Volume574,340

Investment Returns

  • Over 1 Month + 2.78%
  • Over 3 Month + 11.65%
  • Over 6 Month + 9.83%
  • Over 1 Year + 32.69%
SIP Lightning

Smart Investing Starts Here Start SIP with Laurus Labs for Steady Growth!

Invest Now

Laurus Labs Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 201.1
  • PEG Ratio
  • -3.1
  • Market Cap Cr
  • 26,365
  • P/B Ratio
  • 6.4
  • Average True Range
  • 15.4
  • EPS
  • 2.43
  • Dividend Yield
  • 0.2
  • MACD Signal
  • 5.62
  • RSI
  • 53.87
  • MFI
  • 73.28

Laurus Labs Financials

Laurus Labs Technicals

EMA & SMA

Current Price
₹489.00
0 (0%)
pointer
  • stock-down_img
  • Bullish Moving Average 15
  • stock-up_img
  • Bearish Moving Average 1
  • 20 Day
  • ₹484.10
  • 50 Day
  • ₹475.60
  • 100 Day
  • ₹464.44
  • 200 Day
  • ₹446.75

Resistance and Support

489.52 Pivot Speed
  • R3 507.63
  • R2 501.77
  • R1 495.38
  • S1 483.13
  • S2 477.27
  • S3 470.88

What's your outlook on Laurus Labs?

You can only vote for once

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Laurus Labs Ltd. is a leading pharmaceutical company specializing in the development and manufacture of Active Pharmaceutical Ingredients (APIs), focusing on anti-retrovirals, oncology, and cardiovascular treatments. It also provides contract development and manufacturing (CDMO) services globally.

Laurus Labs has an operating revenue of Rs. 5,053.20 Cr. on a trailing 12-month basis. An annual revenue de-growth of -16% needs improvement, Pre-tax margin of 5% is okay, ROE of 3% is fair but needs improvement. The company has a reasonable debt to equity of 19%, which signals a healthy balance sheet. The stock from a technical standpoint is trading close to its 50DMA and comfortably placed above its 200DMA, around 11% above 200DMA. It needs to take support around the 50 DMA level to continue further upside move. It is currently FORMING a base in its weekly chart and is trading around 5% away from the crucial pivot point. From an O'Neil Methodology perspective, the stock has an EPS Rank of 21 which is a POOR score indicating inconsistency in earnings, a RS Rating of 64 which is FAIR indicating the recent price performance, Buyer Demand at A which is evident from recent demand for the stock, Group Rank of 39 indicates it belongs to a strong industry group of Medical-Diversified and a Master Score of C is fair but needs to improve. Institutional holding has gone up in the last reported quarter is a positive sign. Overall, the stock has mediocre technical strength and poor fundamentals, there are superior stocks in the current market environment.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Laurus Labs Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2024-10-24 Quarterly Results & Interim Dividend
2024-07-25 Quarterly Results
2024-04-25 Audited Results & Interim Dividend
2024-01-24 Quarterly Results
2023-10-20 Quarterly Results & Interim Dividend
Date Purpose Remarks
2024-11-06 INTERIM Rs.0.40 per share(20%)Interim Dividend
2024-05-08 INTERIM Rs.0.40 per share(20%)Interim Dividend
2023-11-02 INTERIM Rs.0.40 per share(20%)Interim Dividend
2023-05-10 INTERIM Rs.1.20 per share(60%)Interim Dividend
2022-11-04 INTERIM Rs.0.80 per share(40%)Interim Dividend
Date Purpose Remarks
2020-09-30 Split Rs.0.00 split from Rs. 10/- to Rs. 2/-.

Laurus Labs F&O

Laurus Labs Shareholding Pattern

27.18%
8.25%
4.06%
26.08%
0%
22.67%
11.76%

About Laurus Labs

  • NSE Symbol
  • LAURUSLABS
  • BSE Symbol
  • 540222
  • ISIN
  • INE947Q01028

Similar Stocks to Laurus Labs

Laurus Labs FAQs

Laurus Labs share price is ₹489 As on 21 November, 2024 | 14:29

The Market Cap of Laurus Labs is ₹26364.9 Cr As on 21 November, 2024 | 14:29

The P/E ratio of Laurus Labs is 201.1 As on 21 November, 2024 | 14:29

The PB ratio of Laurus Labs is 6.4 As on 21 November, 2024 | 14:29

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91
 
footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23